Immunomedics Reports Winning of Fast Track Designation for IMMU-132 for Triple-Negative Breast Cancer
January 05, 2015 at 08:32 AM EST
Immunomedics, Inc., (Nasdaq: IMMU) today announced that it has received notice from the U.S. Food and Drug Administration (FDA) ...
